Literature DB >> 28166433

Pro-metastatic p53 mutants control folding of N-glycoproteins.

Jean Schneikert1, Thorsten Stiewe1.   

Abstract

Entities:  

Keywords:  ENTPD5; N-glycosylation; calnexin; calreticulin; mutant p53; protein folding

Mesh:

Substances:

Year:  2017        PMID: 28166433      PMCID: PMC5397256          DOI: 10.1080/15384101.2017.1291247

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  7 in total

1.  The ER UDPase ENTPD5 promotes protein N-glycosylation, the Warburg effect, and proliferation in the PTEN pathway.

Authors:  Min Fang; Zhirong Shen; Song Huang; Liping Zhao; She Chen; Tak W Mak; Xiaodong Wang
Journal:  Cell       Date:  2010-11-11       Impact factor: 41.582

2.  Life or death: p53-induced apoptosis requires DNA binding cooperativity.

Authors:  Katharina Schlereth; Joël P Charles; Anne C Bretz; Thorsten Stiewe
Journal:  Cell Cycle       Date:  2010-10-11       Impact factor: 4.534

Review 3.  Roles of N-linked glycans in the endoplasmic reticulum.

Authors:  Ari Helenius; Markus Aebi
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

4.  Mutant p53 promotes tumor progression and metastasis by the endoplasmic reticulum UDPase ENTPD5.

Authors:  Fotini Vogiatzi; Dominique T Brandt; Jean Schneikert; Jeannette Fuchs; Katharina Grikscheit; Michael Wanzel; Evangelos Pavlakis; Joël P Charles; Oleg Timofeev; Andrea Nist; Marco Mernberger; Eva J Kantelhardt; Udo Siebolts; Frank Bartel; Ralf Jacob; Ariane Rath; Roland Moll; Robert Grosse; Thorsten Stiewe
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-12       Impact factor: 11.205

5.  Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation.

Authors:  Ken S Lau; Emily A Partridge; Ani Grigorian; Cristina I Silvescu; Vernon N Reinhold; Michael Demetriou; James W Dennis
Journal:  Cell       Date:  2007-04-06       Impact factor: 41.582

Review 6.  Mutant p53 in cancer: new functions and therapeutic opportunities.

Authors:  Patricia A J Muller; Karen H Vousden
Journal:  Cancer Cell       Date:  2014-03-17       Impact factor: 31.743

Review 7.  Antiviral therapies targeting host ER alpha-glucosidases: current status and future directions.

Authors:  Jinhong Chang; Timothy M Block; Ju-Tao Guo
Journal:  Antiviral Res       Date:  2013-06-29       Impact factor: 5.970

  7 in total
  1 in total

Review 1.  p53's Extended Reach: The Mutant p53 Secretome.

Authors:  Evangelos Pavlakis; Thorsten Stiewe
Journal:  Biomolecules       Date:  2020-02-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.